Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea

URSAVAŞ, AHMET; KARADAĞ, MEHMET; ORAL, HALUK; DEMİRDÖĞEN, EZGİ; ORAL, HALUK; Ege, Ercuement

doi:10.1016/j.rmed.2008.02.019

Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea

Copy For Citation

URSAVAŞ A., KARADAĞ M., ORAL H. B., DEMİRDÖĞEN E., ORAL H. B., Ege E.

RESPIRATORY MEDICINE, vol.102, no.8, pp.1193-1197, 2008 (SCI-Expanded)

Publication Type: Article / Article
Volume: 102 Issue: 8
Publication Date: 2008
Doi Number: 10.1016/j.rmed.2008.02.019
Journal Name: RESPIRATORY MEDICINE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1193-1197
Keywords: obesity, sleep apnea, daytime sleepiness, neopterin, ACUTE CORONARY SYNDROMES, INSULIN-RESISTANCE, ARTERY-DISEASE, RISK-FACTOR, KAPPA-B, THICKNESS, MARKER, SYSTEM
Bursa Uludag University Affiliated: Yes

Abstract

Objective: Obesity and obstructive sleep apnea (OSA) and systemic inflammation may interact through biochemical pathways. Neopterin (NP) is a monocyte/macrophage activation marker produced by macrophages in response to interferon-gamma secreted by activated T lymphocytes. This study examines the association between NP, obesity and OSA.